Chemical formula: C₁₆H₁₅F₆N₅O Molecular mass: 407.314 g/mol PubChem compound: 4369359
Sitagliptin is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (DPP-4) inhibitors. The improvement in glycaemic control observed with this medicinal product may be mediated by enhancing the levels of active incretin hormones.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A10BH01 | Sitagliptin | A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| JANUVIA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Sitagliptin is an active ingredient of these brands:
United States (US)Australia (AU)Austria (AT)
Brazil (BR)
Croatia (HR)
Cyprus (CY)Ecuador (EC)Estonia (EE)
Finland (FI)France (FR)Hong Kong (HK)Ireland (IE)
Israel (IL)
Italy (IT)Japan (JP)Lithuania (LT)
Malta (MT)
Netherlands (NL)Nigeria (NG)
Poland (PL)
Romania (RO)
South Africa (ZA)
Spain (ES)Tunisia (TN)
Turkey (TR)
United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
